全文获取类型
收费全文 | 3339篇 |
免费 | 314篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 180篇 |
妇产科学 | 62篇 |
基础医学 | 423篇 |
口腔科学 | 33篇 |
临床医学 | 334篇 |
内科学 | 630篇 |
皮肤病学 | 19篇 |
神经病学 | 272篇 |
特种医学 | 124篇 |
外科学 | 474篇 |
综合类 | 115篇 |
一般理论 | 1篇 |
预防医学 | 467篇 |
眼科学 | 62篇 |
药学 | 294篇 |
中国医学 | 3篇 |
肿瘤学 | 159篇 |
出版年
2021年 | 56篇 |
2020年 | 36篇 |
2019年 | 48篇 |
2018年 | 56篇 |
2017年 | 57篇 |
2016年 | 48篇 |
2015年 | 51篇 |
2014年 | 89篇 |
2013年 | 109篇 |
2012年 | 159篇 |
2011年 | 164篇 |
2010年 | 91篇 |
2009年 | 79篇 |
2008年 | 145篇 |
2007年 | 129篇 |
2006年 | 168篇 |
2005年 | 138篇 |
2004年 | 133篇 |
2003年 | 130篇 |
2002年 | 107篇 |
2001年 | 119篇 |
2000年 | 83篇 |
1999年 | 68篇 |
1998年 | 33篇 |
1997年 | 23篇 |
1996年 | 23篇 |
1995年 | 25篇 |
1994年 | 23篇 |
1992年 | 52篇 |
1991年 | 60篇 |
1990年 | 61篇 |
1989年 | 55篇 |
1988年 | 64篇 |
1987年 | 70篇 |
1986年 | 61篇 |
1985年 | 68篇 |
1984年 | 59篇 |
1983年 | 33篇 |
1982年 | 30篇 |
1979年 | 53篇 |
1978年 | 39篇 |
1977年 | 28篇 |
1976年 | 29篇 |
1975年 | 41篇 |
1974年 | 44篇 |
1973年 | 35篇 |
1972年 | 50篇 |
1971年 | 24篇 |
1969年 | 30篇 |
1967年 | 24篇 |
排序方式: 共有3660条查询结果,搜索用时 78 毫秒
91.
92.
93.
94.
95.
Plasma levels of beta-thromboglobulin (BTG) and fibrinopeptide A (FPA), markers of platelet alpha-granule release and thrombin generation respectively, were measured in 27 subjects with transient cerebral ischaemic attacks (TIA), 43 age-matched controls, and 32 young controls. BTG and FPA were both higher in elderly controls than in young controls. BTG was higher in TIA subjects than in age-matched controls and higher in the 12 TIA subjects who had further vascular events in the next year than in those who had no further events. FPA was not significantly associated with TIA or with further events. These results support a relationship between platelet activation and TIA and suggest that BTG levels indicate a group at higher risk of further vascular events. 相似文献
96.
Pleiotropic activities of human interferons are mediated by multiple response pathways. 总被引:1,自引:0,他引:1
下载免费PDF全文
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)
R L Forti W M Mitchell W C Hubbard R J Workman J T Forbes 《Proceedings of the National Academy of Sciences of the United States of America》1984,81(1):170-174
Among the pleiotropic effects of human interferon are the inhibition of viral replication, the activation of natural killer cells, and the inhibition of cellular growth. Oxyphenbutazone, a nonsteroidal antiinflammatory agent, is a potent inhibitor of the antiviral activity of human alpha and beta interferons as determined by cytopathic effect and vesicular stomatitis virus synthesis and release in human foreskin fibroblasts. The inhibition of interferon activity is dose dependent with maximal inhibition at 25-50 microM and minimal inhibition at 1 microM. In contrast, oxyphenbutazone at concentrations as high as 100 microM has no effect on the activation of natural killer cells by human interferon. Similarly, oxyphenbutazone has no inhibitory effect on interferon-induced antigrowth activity in the human breast carcinoma cell line MDA-MB-231. This cell line is sensitive to oxyphenbutazone inhibition of interferon-induced antiviral activity in vitro. In another human cell line, the vulvar carcinoma A431, oxyphenbutazone apparently augments the antigrowth activity of interferon. Although oxyphenbutazone inhibits the fatty acid cyclooxygenase enzyme in these systems, other inhibitors of cyclooxygenase fail to inactivate the antiviral activity of human interferon. Thus, oxyphenbutazone appears to inhibit the interferon antiviral cascade at a site distinct from prostaglandin biosynthesis. Moreover, the failure to inhibit natural killer cell activation or cellular antigrowth effects of human interferon suggests a pathway different from that associated with the antiviral effect of human interferon. 相似文献
97.
98.
99.
B. Joseph Elmunzer Rebecca L. Spitzer Lydia D. Foster Ambreen A. Merchant Eric F. Howard Vaishali A. Patel Mary K. West Emad Qayed Rosemary Nustas Ali Zakaria Marc S. Piper Jason R. Taylor Lujain Jaza Nauzer Forbes Millie Chau Luis F. Lara Georgios I. Papachristou Michael L. Volk Valerie Durkalski 《Clinical gastroenterology and hepatology》2021,19(7):1355-1365.e4
100.
A R Saniabadi G D Lowe R Madhok K Spowart B Shaw J C Barbenel C D Forbes 《Atherosclerosis》1987,66(3):175-180
The influence of red blood cells on spontaneous platelet aggregation (SPA) has been studied ex vivo. Platelet aggregation was quantified by measuring the fall in single platelet count using a new whole blood platelet counter. When aliquots of whole blood and autologous platelet rich plasma (PRP) were roller-mixed at 37 degrees C, a marked fall in platelet count occurred in whole blood due to SPA but platelet count remained almost unchanged in PRP. When blood from healthy young controls, aged 20-35 years, was compared with healthy old controls, aged 48-80 years, and patients with thrombotic complications, the extent of SPA was in the order: thrombotic patients greater than old controls greater than young controls. Prostacyclin and the new stable prostacyclin analogue Iloprost, at 8 nM effectively inhibited SPA. 2-Chloroadenosine (10 microM) which is an inhibitor of ADP-induced platelet aggregation was also an effective inhibitor of SPA. Acetylsalicylic acid (56 microM) and the thromboxane A2 receptor blocker BM13.177 (0.5 microM) only partially inhibited SPA. ADP from red blood cells is suspected to mediate red cell-induced SPA. However, the possibility that the red cells have an important physical role in SPA cannot be ruled out. 相似文献